(Q36777053)

16 August 2017

title

Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells (English)

1 reference

16 August 2017

1 reference

4

Dinarello CA

1 reference

16 August 2017

5

Mantovani A

1 reference

16 August 2017

Re F

1

1 reference

16 August 2017

Mengozzi M

series ordinal

2

1 reference

16 August 2017

Muzio M

series ordinal

3

1 reference

16 August 2017

Colotta F

series ordinal

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

European Journal of Immunology

16 August 2017

published in

1 reference

16 August 2017

volume

23

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

570-573

1 reference

There is more than one interleukin 1.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Expression of c-fos protooncogene in normal human peripheral blood granulocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Differential expression of Raf-1 protooncogene in resting and activated human leukocyte populations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Functional and metabolic properties of polymorphonuclear leucocytes. II. The influence of a lipopolysaccharide endotoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230242

7 January 2021

Identifiers

DOI

10.1002/EJI.1830230242

1 reference

16 August 2017

1 reference